Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Sumant Kulkarni is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.17 | 498.29% | $7 → $7 | Maintains | Buy | Get Alert |
| 06/20/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 54.73% | $107 → $113 | Maintains | Buy | Get Alert |
| 06/13/2024 | CARA | Buy Now | Cara Therapeutics | $0.32 | 213.48% | $10 → $1 | Downgrade | Buy → Hold | Get Alert |
| 05/07/2024 | STOK | Buy Now | Stoke Therapeutics | $13.58 | 47.28% | $21 → $20 | Maintains | Buy | Get Alert |
| 05/06/2024 | GHRS | Buy Now | GH Research | $11.05 | 180.54% | $30 → $31 | Maintains | Buy | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | 12.57% | $154 → $164 | Maintains | Buy | Get Alert |
| 04/30/2024 | ANVS | Buy Now | Annovis Bio | $11.21 | 131.94% | $36 → $26 | Maintains | Buy | Get Alert |
| 04/26/2024 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 37.21% | $21 → $17 | Maintains | Hold | Get Alert |
| 04/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 46.52% | $100 → $107 | Maintains | Buy | Get Alert |
| 04/08/2024 | CRVO | Buy Now | CervoMed | $16.58 | 292.04% | $50 → $65 | Maintains | Buy | Get Alert |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $13.58 | 54.64% | $18 → $21 | Maintains | Buy | Get Alert |
| 03/14/2024 | BTAI | Buy Now | BioXcel Therapeutics | $1.17 | 498.29% | $18 → $7 | Maintains | Buy | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 85.92% | $40 → $33 | Maintains | Buy | Get Alert |
| 03/06/2024 | CARA | Buy Now | Cara Therapeutics | $0.32 | 3034.8% | $11 → $10 | Maintains | Buy | Get Alert |
| 02/23/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 36.93% | $101 → $100 | Maintains | Buy | Get Alert |
| 02/20/2024 | BIIB | Buy Now | Biogen | $226.40 | 34.72% | $310 → $305 | Maintains | Buy | Get Alert |
| 02/15/2024 | CRVO | Buy Now | CervoMed | $16.58 | 201.57% | → $50 | Initiates | → Buy | Get Alert |
| 12/29/2023 | ANVS | Buy Now | Annovis Bio | $11.21 | 221.14% | → $36 | Initiates | → Buy | Get Alert |
| 12/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | 2.96% | → $150 | Reiterates | Buy → Buy | Get Alert |
| 11/06/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 125.35% | $38 → $40 | Maintains | Buy | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -1.16% | $132 → $144 | Maintains | Buy | Get Alert |
| 09/01/2023 | ZVRA | Buy Now | Zevra Therapeutics | $6.10 | 227.87% | → $20 | Reiterates | Buy → Buy | Get Alert |
| 09/01/2023 | CYBN | Buy Now | Cybin | $0.30 | 1567.22% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | CMPS | Buy Now | Compass Pathways | $7.15 | 599.11% | $60 → $50 | Maintains | Buy | Get Alert |
| 08/16/2023 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | $10 → $1.11 | Downgrade | Buy → Hold | Get Alert |
| 08/15/2023 | ZVRA | Buy Now | Zevra Therapeutics | $6.10 | 227.87% | $19 → $20 | Maintains | Buy | Get Alert |
| 08/15/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.17 | 1609.4% | $76 → $20 | Maintains | Buy | Get Alert |
| 08/11/2023 | CYBN | Buy Now | Cybin | $0.30 | 1567.22% | $6 → $5 | Maintains | Buy | Get Alert |
| 08/08/2023 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 69.49% | $64 → $21 | Downgrade | Buy → Hold | Get Alert |
| 08/03/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 114.08% | $39 → $38 | Maintains | Buy | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -9.4% | $130 → $132 | Maintains | Buy | Get Alert |
| 07/17/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 119.72% | $28 → $39 | Maintains | Buy | Get Alert |
| 07/03/2023 | CYBN | Buy Now | Cybin | $0.30 | 1900.67% | $7 → $6 | Maintains | Buy | Get Alert |
| 06/12/2023 | BIIB | Buy Now | Biogen | $226.40 | 54.59% | $330 → $350 | Maintains | Buy | Get Alert |
| 05/10/2023 | VYGR | Buy Now | Voyager Therapeutics | $8.37 | 67.26% | $10 → $14 | Maintains | Buy | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -10.77% | $132 → $130 | Maintains | Buy | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $226.40 | 45.76% | $325 → $330 | Maintains | Buy | Get Alert |
| 04/26/2023 | STOK | Buy Now | Stoke Therapeutics | $13.58 | 76.73% | → $24 | Assumes | → Buy | Get Alert |
| 03/30/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -9.4% | $124 → $132 | Upgrade | Hold → Buy | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $73.03 | 34.19% | $93 → $98 | Maintains | Buy | Get Alert |
| 03/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 46.48% | $24 → $26 | Maintains | Buy | Get Alert |
| 03/07/2023 | CARA | Buy Now | Cara Therapeutics | $0.32 | 7736.99% | $29 → $25 | Maintains | Buy | Get Alert |
| 11/11/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.17 | 6395.73% | $75 → $76 | Maintains | Buy | Get Alert |
| 10/04/2022 | CLNN | Buy Now | Clene | $4.47 | 34.23% | $200 → $120 | Maintains | Buy | Get Alert |
| 09/15/2022 | KMPH | Buy Now | KemPharm | — | — | → $20 | Initiates | → Buy | Get Alert |
| 06/23/2022 | ZYNE | Buy Now | Zynerba Pharmaceuticals | — | — | $9 → $11 | Maintains | Buy | Get Alert |
| 05/02/2022 | CLNN | Buy Now | Clene | $4.47 | 123.71% | → $200 | Initiates | → Buy | Get Alert |
| 04/13/2022 | GHRS | Buy Now | GH Research | $11.05 | 271.04% | $45 → $41 | Maintains | Buy | Get Alert |
| 03/16/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 74.65% | $30 → $31 | Upgrade | Hold → Buy | Get Alert |
| 03/14/2022 | CARA | Buy Now | Cara Therapeutics | $0.32 | 8990.91% | $33 → $29 | Maintains | Buy | Get Alert |
| 02/07/2022 | BIIB | Buy Now | Biogen | $226.40 | 34.72% | $335 → $305 | Maintains | Buy | Get Alert |
| 01/28/2022 | CRTX | Buy Now | Cortexyme | — | — | — | Downgrade | Buy → Hold | Get Alert |
| 12/22/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 69.01% | $26 → $30 | Maintains | Hold | Get Alert |
